223 related articles for article (PubMed ID: 21220488)
1. Glutathione-conjugate transport by RLIP76 is required for clathrin-dependent endocytosis and chemical carcinogenesis.
Singhal SS; Wickramarachchi D; Yadav S; Singhal J; Leake K; Vatsyayan R; Chaudhary P; Lelsani P; Suzuki S; Yang S; Awasthi YC; Awasthi S
Mol Cancer Ther; 2011 Jan; 10(1):16-28. PubMed ID: 21220488
[TBL] [Abstract][Full Text] [Related]
2. RLIP76 Inhibition: A Promising Developmental Therapy for Neuroblastoma.
Singhal SS; Nagaprashantha L; Singhal P; Singhal S; Singhal J; Awasthi S; Horne D
Pharm Res; 2017 Aug; 34(8):1673-1682. PubMed ID: 28386633
[TBL] [Abstract][Full Text] [Related]
3. Activating p53 function by targeting RLIP.
Singhal SS; Horne D; Singhal J; Awasthi S; Salgia R
Biochim Biophys Acta Rev Cancer; 2021 Apr; 1875(2):188512. PubMed ID: 33460725
[TBL] [Abstract][Full Text] [Related]
4. RLIP76: A novel glutathione-conjugate and multi-drug transporter.
Singhal SS; Yadav S; Roth C; Singhal J
Biochem Pharmacol; 2009 Mar; 77(5):761-9. PubMed ID: 18983828
[TBL] [Abstract][Full Text] [Related]
5. Mitogenic and drug-resistance mediating effects of PKCalpha require RLIP76.
Singhal SS; Yadav S; Singhal J; Awasthi YC; Awasthi S
Biochem Biophys Res Commun; 2006 Sep; 348(2):722-7. PubMed ID: 16890208
[TBL] [Abstract][Full Text] [Related]
6. The non-ABC drug transporter RLIP76 (RALBP-1) plays a major role in the mechanisms of drug resistance.
Awasthi YC; Sharma R; Yadav S; Dwivedi S; Sharma A; Awasthi S
Curr Drug Metab; 2007 May; 8(4):315-23. PubMed ID: 17504221
[TBL] [Abstract][Full Text] [Related]
7. Determinants of differential doxorubicin sensitivity between SCLC and NSCLC.
Singhal SS; Wickramarachchi D; Singhal J; Yadav S; Awasthi YC; Awasthi S
FEBS Lett; 2006 Apr; 580(9):2258-64. PubMed ID: 16579994
[TBL] [Abstract][Full Text] [Related]
8. RLIP: A necessary transporter protein for translating oxidative stress into pro-obesity and pro-carcinogenic signaling.
Singhal SS; Garg R; Horne D; Singhal S; Awasthi S; Salgia R
Biochim Biophys Acta Rev Cancer; 2022 Sep; 1877(5):188803. PubMed ID: 36150564
[TBL] [Abstract][Full Text] [Related]
9. Targeting p53-null neuroblastomas through RLIP76.
Singhal J; Yadav S; Nagaprashantha LD; Vatsyayan R; Singhal SS; Awasthi S
Cancer Prev Res (Phila); 2011 Jun; 4(6):879-89. PubMed ID: 21411502
[TBL] [Abstract][Full Text] [Related]
10. RLIP76 in defense of radiation poisoning.
Singhal J; Singhal SS; Yadav S; Suzuki S; Warnke MM; Yacoub A; Dent P; Bae S; Sharma R; Awasthi YC; Armstrong DW; Awasthi S
Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):553-61. PubMed ID: 18793957
[TBL] [Abstract][Full Text] [Related]
11. Rlip76 transports sunitinib and sorafenib and mediates drug resistance in kidney cancer.
Singhal SS; Sehrawat A; Sahu M; Singhal P; Vatsyayan R; Rao Lelsani PC; Yadav S; Awasthi S
Int J Cancer; 2010 Mar; 126(6):1327-38. PubMed ID: 19626587
[TBL] [Abstract][Full Text] [Related]
12. RLIP76 is a major determinant of radiation sensitivity.
Awasthi S; Singhal SS; Yadav S; Singhal J; Drake K; Nadkar A; Zajac E; Wickramarachchi D; Rowe N; Yacoub A; Boor P; Dwivedi S; Dent P; Jarman WE; John B; Awasthi YC
Cancer Res; 2005 Jul; 65(14):6022-8. PubMed ID: 16024601
[TBL] [Abstract][Full Text] [Related]
13. RLIP controls receptor-ligand signaling by regulating clathrin-dependent endocytosis.
Singhal SS; Salgia R; Verma N; Horne D; Awasthi S
Biochim Biophys Acta Rev Cancer; 2020 Jan; 1873(1):188337. PubMed ID: 31904398
[TBL] [Abstract][Full Text] [Related]
14. A central role of RLIP76 in regulation of glycemic control.
Awasthi S; Singhal SS; Yadav S; Singhal J; Vatsyayan R; Zajac E; Luchowski R; Borvak J; Gryczynski K; Awasthi YC
Diabetes; 2010 Mar; 59(3):714-25. PubMed ID: 20007934
[TBL] [Abstract][Full Text] [Related]
15. RLIP76 Targeted Therapy for Kidney Cancer.
Singhal SS; Singhal J; Figarola J; Horne D; Awasthi S
Pharm Res; 2015 Oct; 32(10):3123-36. PubMed ID: 26021465
[TBL] [Abstract][Full Text] [Related]
16. Transport of glutathione conjugates and chemotherapeutic drugs by RLIP76 (RALBP1): a novel link between G-protein and tyrosine kinase signaling and drug resistance.
Awasthi S; Singhal SS; Sharma R; Zimniak P; Awasthi YC
Int J Cancer; 2003 Sep; 106(5):635-46. PubMed ID: 12866021
[TBL] [Abstract][Full Text] [Related]
17. Physiological and pharmacological significance of glutathione-conjugate transport.
Awasthi YC; Chaudhary P; Vatsyayan R; Sharma A; Awasthi S; Sharma R
J Toxicol Environ Health B Crit Rev; 2009 Aug; 12(7):540-51. PubMed ID: 20183533
[TBL] [Abstract][Full Text] [Related]
18. Regression of lung and colon cancer xenografts by depleting or inhibiting RLIP76 (Ral-binding protein 1).
Singhal SS; Singhal J; Yadav S; Dwivedi S; Boor PJ; Awasthi YC; Awasthi S
Cancer Res; 2007 May; 67(9):4382-9. PubMed ID: 17483352
[TBL] [Abstract][Full Text] [Related]
19. Depletion of RLIP76 sensitizes lung cancer cells to doxorubicin.
Singhal SS; Yadav S; Singhal J; Zajac E; Awasthi YC; Awasthi S
Biochem Pharmacol; 2005 Aug; 70(3):481-8. PubMed ID: 15950949
[TBL] [Abstract][Full Text] [Related]
20. Linking stress-signaling, glutathione metabolism, signaling pathways and xenobiotic transporters.
Yadav S; Zajac E; Singhal SS; Awasthi S
Cancer Metastasis Rev; 2007 Mar; 26(1):59-69. PubMed ID: 17260165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
